Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-10-18 16:17:44
Reporting Period:
Accepted Time:
2017-10-18 16:17:44
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1138776 Aevi Genomic Medicine Inc. GNMX Biological Products, (No Disgnostic Substances) (2836) 980217544
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188940 F Michael Cola C/o Aevi Genomic Medicine, Inc.
435 Devon Park Drive, Suite 715
Wayne PA 19087
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-17 119,047 $1.26 218,483 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy) Acquisiton 2017-10-17 21,181 $0.00 21,181 $2.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,181 2017-10-17 2022-10-17 No 4 P Direct